JP2012524781A - 虚血性及び糖尿病性創傷の治癒を促進する組成物、キット及び方法 - Google Patents

虚血性及び糖尿病性創傷の治癒を促進する組成物、キット及び方法 Download PDF

Info

Publication number
JP2012524781A
JP2012524781A JP2012507248A JP2012507248A JP2012524781A JP 2012524781 A JP2012524781 A JP 2012524781A JP 2012507248 A JP2012507248 A JP 2012507248A JP 2012507248 A JP2012507248 A JP 2012507248A JP 2012524781 A JP2012524781 A JP 2012524781A
Authority
JP
Japan
Prior art keywords
selectin
wound
sdf
protein
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2012507248A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012524781A5 (enExample
Inventor
ヴェラズクエズ，オマイダ，シー．
リウ，ザオ‐ジュン
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Miami
Original Assignee
University of Miami
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Miami filed Critical University of Miami
Publication of JP2012524781A publication Critical patent/JP2012524781A/ja
Publication of JP2012524781A5 publication Critical patent/JP2012524781A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/195—Chemokines, e.g. RANTES
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/7056—Lectin superfamily, e.g. CD23, CD72
    • C07K14/70564—Selectins, e.g. CD62
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Obesity (AREA)
  • Nutrition Science (AREA)
  • Hematology (AREA)
  • Biotechnology (AREA)
  • Physiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2012507248A 2009-04-21 2010-04-09 虚血性及び糖尿病性創傷の治癒を促進する組成物、キット及び方法 Pending JP2012524781A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17127109P 2009-04-21 2009-04-21
US61/171,271 2009-04-21
PCT/US2010/030471 WO2010123699A2 (en) 2009-04-21 2010-04-09 Compositions, kits and methods for promoting ischemic and diabetic wound healing

Publications (2)

Publication Number Publication Date
JP2012524781A true JP2012524781A (ja) 2012-10-18
JP2012524781A5 JP2012524781A5 (enExample) 2013-05-30

Family

ID=43011688

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012507248A Pending JP2012524781A (ja) 2009-04-21 2010-04-09 虚血性及び糖尿病性創傷の治癒を促進する組成物、キット及び方法

Country Status (6)

Country Link
US (1) US20120058086A1 (enExample)
EP (1) EP2421967A4 (enExample)
JP (1) JP2012524781A (enExample)
KR (1) KR20120023633A (enExample)
CN (1) CN102421894A (enExample)
WO (1) WO2010123699A2 (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016516071A (ja) * 2013-03-15 2016-06-02 ユベンタス セラピューティクス，インコーポレイテッド 瘢痕形成を軽減するためのｓｄｆ−１の使用

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10696974B2 (en) 2014-12-23 2020-06-30 Ilya Pharma Ab Methods for wound healing
US20180028108A1 (en) * 2015-03-18 2018-02-01 Bio1 Systems, Llc Digital wound assessment device and method
CN106581068A (zh) * 2016-11-08 2017-04-26 广州医科大学附属第三医院 一种可以快速恢复皮肤创面的生物膜及其制备方法
KR20200013674A (ko) * 2017-05-02 2020-02-07 유니버시티 오브 마이애미 허혈 조직을 치료하는 방법

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008118370A2 (en) * 2007-03-22 2008-10-02 The Trustees Of The University Of Pennsylvania Hyperbaric treatment in wound healing

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20070244043A1 (en) * 2005-03-10 2007-10-18 Novavax, Inc. Recombinant E-selectin made in insect cells

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008118370A2 (en) * 2007-03-22 2008-10-02 The Trustees Of The University Of Pennsylvania Hyperbaric treatment in wound healing

Non-Patent Citations (4)

* Cited by examiner, † Cited by third party
Title
JPN6014019975; ＧＡＬＬＡＧＨＥＲ　Ｋ　Ａ　ｅｔ　ａｌ: Ｊｏｕｒｎａｌ　ｏｆ　ｔｈｅ　Ａｍｅｒｉｃａｎ　Ｃｏｌｌｅｇｅ　ｏｆ　Ｓｕｒｇｅｏｎｓ , 20030901, Ｓ４０ *
JPN6014019977; ＯＨ　ＩＩ　Ｙｏｕｎｇ　ｅｔ　ａｌ: Ｂｌｏｏｄ ｖｏｌ．１１０，　ｎｏ．１２, 2007, ｐ．３８９１-３８９９ *
JPN6014019979; Ｎｉｓｈｉｗａｋｉ　Ｙ　ｅｔ　ａｌ: Ａｒｔｅｒｉｏｓｃｌｅｒ　Ｔｈｒｏｍｂ　Ｖａｓｃ　Ｂｉｏｌ． ｖｏｌ．２７，　ｎｏ．　３, 200703, ｐ．５１２-５１８ *
JPN6014019980; Ｃｈｅｎ　Ｆｅｎｇ　ｅｔ　ａｌ: Ｅｕｒ　Ｊ　Ｐｈａｒｍａｃｏｌ ｖｏｌ．５６８, 2007, ｐ．２２２-２３０ *

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2016516071A (ja) * 2013-03-15 2016-06-02 ユベンタス セラピューティクス，インコーポレイテッド 瘢痕形成を軽減するためのｓｄｆ−１の使用

Also Published As

Publication number Publication date
WO2010123699A2 (en) 2010-10-28
CN102421894A (zh) 2012-04-18
EP2421967A2 (en) 2012-02-29
US20120058086A1 (en) 2012-03-08
EP2421967A4 (en) 2013-01-02
KR20120023633A (ko) 2012-03-13
WO2010123699A3 (en) 2011-01-06

Similar Documents

Publication Publication Date Title
Zhang et al. Enhancing efficacy of stem cell transplantation to the heart with a PEGylated fibrin biomatrix
CA2504019C (en) Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration in ischemic cardiomyopathy
US20040161412A1 (en) Cell-based VEGF delivery
US20150139952A1 (en) Methods, compositions, cells, and kits for treating ischemic injury
Kim et al. Bone marrow mononuclear cells have neurovascular tropism and improve diabetic neuropathy
US9226978B2 (en) Method of treating ischemic disorders
Xu et al. Rosuvastatin treatment activates JAK-STAT pathway and increases efficacy of allogeneic mesenchymal stem cell transplantation in infarcted hearts
Zhang et al. C1q/tumor necrosis factor-related protein-3-engineered mesenchymal stromal cells attenuate cardiac impairment in mice with myocardial infarction
Liu et al. Identification of E-selectin as a novel target for the regulation of postnatal neovascularization: implications for diabetic wound healing
JP2012524781A (ja) 虚血性及び糖尿病性創傷の治癒を促進する組成物、キット及び方法
JP7450244B2 (ja) 虚血組織を治療するための方法
US8580739B2 (en) Methods of reducing myocardial injury following myocardial infarction
EP2964330B1 (en) Compositions and methods for cardiac tissue repair
CN108606981B (zh) 运用MSCs定向趋化特性运载EPO治疗肺纤维化
US20220280607A1 (en) Treatment of Heart Defects and Conditions in Pediatric Patients
CN114984184A (zh) 增强tbx1表达在修复心脏组织损伤中的用途
US20240238346A1 (en) Myocardial wound healing post ischemic injury
JP2020174573A (ja) 虚血組織に集積するエクソソームおよびその製造方法
Merentie Cardiological studies in mice: special emphasis on gene therapy, imaging and ECG findings
KR20230137808A (ko) 지방 조직 유래 중간엽 줄기세포 및 인간 기질 혈관 분획을 포함하는 혈관신생 촉진용 조성물
AU2010241483B2 (en) Stromal cell-derived factor-1 mediates stem cell homing and tissue regeneration
JP2006519873A (ja) 血管形成を促進するための腫瘍内皮マーカー１、９、および１７の使用

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20130409

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20130409

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20140520

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140819

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140826

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20140919

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20140929

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20141017

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20141024

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20141120

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20141120

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20150512